Arcellx News

Arcellx | 8-K: Arcellx Provides First Quarter 2024 Financial Results

May 10 05:09

Arcellx | DEFA14A: Others

Apr 12 04:40

Arcellx | DEF 14A: Definitive information statements

Apr 12 04:30

Arcellx | 8-K: Current report

Mar 15 04:22

Arcellx | 8-K: Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights

Feb 29 05:11

Arcellx | 8-K: Current report

Feb 1 05:24

Arcellx | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jan 2 13:00

Arcellx | 8-K: Current report

Dec 28, 2023 13:00

Arcellx | 8-K: Current report

Dec 12, 2023 20:37

Arcellx | 8-K: Current report

Dec 9, 2023 06:16

Arcellx | 8-K: Current report

Nov 15, 2023 19:16

Arcellx | 8-K: Arcellx Provides Third Quarter 2023 Financial Results and Business Highlights

Nov 14, 2023 05:05

Arcellx | 8-K: Current report

Nov 2, 2023 21:13

Arcellx | 8-K: Arcellx Announces Partial Clinical Hold Lifted on iMMagine-1 Phase 2 Clinical Program and Reports Second Quarter Financial Results

Aug 15, 2023 04:06

Arcellx | 8-K: Current report

Jun 20, 2023 18:10

Arcellx | 8-K: Current report

Jun 15, 2023 04:15

Arcellx | 8-K: Current report

May 9, 2023 05:21

Arcellx | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

May 9, 2023 05:02

Arcellx | 8-K: Arcellx Provides First Quarter Financial Results

May 9, 2023 04:02

Arcellx | DEFA14A: Others

Apr 29, 2023 04:07